Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a common cause of hospitalisation and death among COPD patients. Several biochemical markers have been studied as outcome predictors in COPD; however, their measurement often requires significant time and resources. Relatively simple biomarkers of inflammation calculated from routine complete blood count tests, such as the neutrophil to lymphocyte ratio (NLR), might also predict COPD progression and outcomes. This review discusses the available evidence from studies investigating the associations between the NLR, COPD exacerbations and death in this patient group.

Neutrophil to lymphocyte ratio and clinical outcomes in copd: Recent evidence and future perspectives / Paliogiannis, Panagiotis; Fois, Alessandro G.; Sotgia, Salvatore; Mangoni, Arduino A.; Zinellu, Elisabetta; Pirina, Pietro; Negri, Silvia; Carru, Ciriaco; Zinellu, Angelo. - In: EUROPEAN RESPIRATORY REVIEW. - ISSN 0905-9180. - 27:147(2018), p. 170113. [10.1183/16000617.0113-2017]

Neutrophil to lymphocyte ratio and clinical outcomes in copd: Recent evidence and future perspectives

Paliogiannis, Panagiotis;Fois, Alessandro G.;Sotgia, Salvatore;Mangoni, Arduino A.;Zinellu, Elisabetta;Pirina, Pietro;NEGRI, Silvia;Carru, Ciriaco;Zinellu, Angelo
2018

Abstract

Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a common cause of hospitalisation and death among COPD patients. Several biochemical markers have been studied as outcome predictors in COPD; however, their measurement often requires significant time and resources. Relatively simple biomarkers of inflammation calculated from routine complete blood count tests, such as the neutrophil to lymphocyte ratio (NLR), might also predict COPD progression and outcomes. This review discusses the available evidence from studies investigating the associations between the NLR, COPD exacerbations and death in this patient group.
Neutrophil to lymphocyte ratio and clinical outcomes in copd: Recent evidence and future perspectives / Paliogiannis, Panagiotis; Fois, Alessandro G.; Sotgia, Salvatore; Mangoni, Arduino A.; Zinellu, Elisabetta; Pirina, Pietro; Negri, Silvia; Carru, Ciriaco; Zinellu, Angelo. - In: EUROPEAN RESPIRATORY REVIEW. - ISSN 0905-9180. - 27:147(2018), p. 170113. [10.1183/16000617.0113-2017]
File in questo prodotto:
File Dimensione Formato  
Paliogiannis Eur Resp Rev 2018.pdf

accesso aperto

Tipologia: Versione editoriale (versione finale pubblicata)
Licenza: Creative commons
Dimensione 304.69 kB
Formato Adobe PDF
304.69 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11388/200911
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 71
  • ???jsp.display-item.citation.isi??? 71
social impact